GenScript LNP Solutions: Ready-Edit and Targeted LNP services
GenScript’s Ready-Edit and Targeted LNP services enable precise gene editing and targeted RNA delivery for advanced therapeutics. Ready-Edit LNPs co-encapsulate CRISPR components for efficient gene modifications, while Targeted LNPs use customizable ligands for accurate payload delivery. Maximize efficacy, minimize off-target effects, and accelerate your research with GenScript’s cutting-edge solutions.
Receive your quote directly from the manufacturer.
GenScript’s LNP Packaging Service provides a flexible, scalable solution tailored to your project’s specific needs. With a diverse range of LNP formulation options, payload sizes, and loading capacities, along with comprehensive QC testing, our streamlined manufacturing platform accelerates your gene-to-mRNA-to-delivery workflow. Whether for research or therapeutic applications, GenScript’s optimized LNP technology ensures high-quality, reproducible results to advance RNA-based innovations.
The Ready-Edit LNP Service delivers precision-engineered lipid nanoparticles designed for efficient gene editing applications. By co-encapsulating CRISPR components like Cas9 and guide RNA, these LNPs enable precise gene modifications with minimal off-target effects, streamlining gene knock-in, knock-out, and base editing. Meanwhile, GenScript’s Targeted LNP Service enhances RNA and gene therapy delivery through custom ligands and antibodies, ensuring tissue- and cell-specific targeting for applications in oncology, regenerative medicine, and vaccine development. With specialized LNPs for T cells, lungs, spleen, tumors, brain, liver, and macrophages, GenScript’s cutting-edge formulations maximize efficacy while minimizing systemic exposure, advancing next-generation RNA therapeutics.
